Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease
Authors:
- 28 July 2009
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 109 (10) , 4885-4910
Abstract
No abstract availableKeywords
This publication has 313 references indexed in Scilit:
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- Animal models of Parkinson’s disease progressionActa Neuropathologica, 2008
- Copper binding to the Alzheimer’s disease amyloid precursor proteinEuropean Biophysics Journal, 2007
- The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in miceJournal of Neural Transmission, 2006
- Friedreich ataxia?update on pathogenesis and possible therapiesneurogenetics, 2004
- CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's diseaseJournal of Neural Transmission, 2000
- Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Physical, Morphological and Functional Differences between pH 5.8 and 7.4 Aggregates of the Alzheimer's Amyloid Peptide A βJournal of Molecular Biology, 1996
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 1988
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984